Clinical Trials Logo

Clinical Trial Summary

The proposed pilot project for this seed grant focuses on the role of intestinal serine-proteases in the pathogenesis of diarrhea-predominant IBS (D-IBS). In this study we will further assess serine-protease activity in patients with D-IBS and also explore a possible mechanism by which these proteases can lead to alterations in intestinal physiology and symptoms in these patients.

The general hypotheses for the proposed research are that (A) the levels of fecal serine-protease in patients with D-IBS are abnormally increased (B) this abnormal serine-protease activity leads to/is associated with an abnormal increase in intestinal permeability and therefore enables (C) chronic stimulation and activation of the mucosal immune system in these patients. In addition, it is aim to determine whither periodontal inflammation is associated with intestinal permeability and serine protease activity.


Clinical Trial Description

n/a


Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01072916
Study type Observational
Source University of North Carolina, Chapel Hill
Contact
Status Completed
Phase N/A
Start date February 2009
Completion date December 2015

See also
  Status Clinical Trial Phase
Recruiting NCT06291272 - Effect of Methylcellulose or Psyllium on Fermentation of inUlin Assessed USing MRI N/A
Completed NCT01176227 - Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome (IBS) Phase 1/Phase 2
Completed NCT01887834 - Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome Phase 1/Phase 2
Completed NCT01072903 - The Role of Intestinal Inflammation in Irritable Bowel Syndrome (IBS) N/A